References Full guideline: Wyckoff J, Lapolla A, Asias-Dinh B et al
Michael Palladinetti, global head of business development and licensing at Sanofi, told delegates attending Bio Europe Spring in Barcelona, Spain last week that history has shown us time and time again that no one has the monopoly on the next wave of innovation. Citing the recent GLP-1 wave, Palladinetti said the industry has a bit of fear of missing out (FOMO) and paid kudos to Lily and Novo for staying in the space. He added how innovation is also very difficult and that industry players need to have a broad view. Both firms are pioneers in the diabetes space, having launched their own versions of insulin over 100 years ago
Evans M, McEwan P, OShea R, George L
10.2337/dc06-1815 108
Diabetes care teams who understand how to navigate GLP1 therapy in the surgical setting will not only reduce complications but also enhance long-term outcomes for their patients
Slowing digestion : Food will pass slower through your digestive system, keeping you feeling full longer